20.1 C
New York
Thursday, June 4, 2026

Tag: viruses

newssourceFORcompanyinformationcontent1marketreleases

Cocamidopropyl Betaine (CAPB) Market Size to Reach USD 1.45 Billion by 2033, Driven by Growing Demand for Mild Surfactant Systems, Regulatory-Aligned Formulations, and Expanding...

Verified Market Research® Reports Rising Adoption Across Personal Care, Household Cleaning, Industrial Cleaning, and Agrochemical Formulations as Manufacturers Prioritize Foam Stability, Cleansing Performance, Formulation...

Cocamidopropyl Betaine (CAPB) Market Size to Reach USD 1.45 Billion by 2033, Driven by Growing Demand for Mild Surfactant Systems, Regulatory-Aligned Formulations, and Expanding...

Verified Market Research® Reports Rising Adoption Across Personal Care, Household Cleaning, Industrial Cleaning, and Agrochemical Formulations as Manufacturers Prioritize Foam Stability, Cleansing Performance, Formulation...

Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

– Live video webcast on Wednesday, August 20th at 2:00 PM ET

Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene’s Platform Technology

NEW YORK, Aug. 12, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO), announces that it signed a binding agreement to initiate manufacturing and development...

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

SAN DIEGO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, today reported its second quarter 2025 operating and financial results and reviewed recent business highlights.

DMG Blockchain Solutions Announces Preliminary July Operational Results, Treasury Update, Launch of Blockseer Explorer

VANCOUVER, British Columbia, Aug. 06, 2025 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB: DMGGF) (FRANKFURT: 6AX) ("DMG" or the "Company"), a vertically integrated blockchain and data center technology company, today announces its preliminary operational results for July 2025:

Stoneridge Reports Second Quarter 2025 Results

MirrorEye® Sets Another Quarterly Sales Record Announces Largest Business Award in Company History for Global MirrorEye Program Announces Largest OEM Business Award in Stoneridge Brazil History Announces...

Extra Space Storage Inc. Reports 2025 Second Quarter Results

SALT LAKE CITY, July 30, 2025 /PRNewswire/ -- Extra Space Storage Inc. (NYSE: EXR) (the "Company"), a leading owner and operator of self-storage facilities...

Vystar Introduces New RxAir-800 Replacement Cartridge Extended Life UV-C Bulb

New RxAir400 Pro UV-C bulb replacement cartridge provides 18,000 vs 9,000 hr. use.

Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin

– New patent enhances market position in Europe

MetrioPharm’s MP1032 Receives EMA Orphan Drug Designation in Duchenne Muscular Dystrophy

Zurich, July 29, 2025 – MetrioPharm AG, a pharmaceutical company developing drugs for inflammatory and infectious diseases, announced today that the European Medicines Agency has granted Orphan Drug Designation (ODD) to its lead compound, MP1032 for the treatment of children affected by Duchenne muscular dystrophy (DMD). This milestone follows the U.S. FDA's ODD, underscoring MP1032's potential as a first-in-class therapy that could minimize reliance on high-dose corticosteroids, which cause severe side effects like osteoporosis, growth stunting, and metabolic issues.

DEFENSE METALS SETTLES DEBT WITH HATCH THROUGH EQUITY

VANCOUVER, BC, July 28, 2025 /CNW/ - Defense Metals Corp. ("Defense Metals" or the "Company" (TSXV: DEFN) (OTCQB: DFMTF) (FSE: 35D) announces that it has...

DEFENSE METALS SETTLES DEBT WITH HATCH THROUGH EQUITY

VANCOUVER, BC, July 28, 2025 /PRNewswire/ - Defense Metals Corp. ("Defense Metals" or the "Company" (TSXV: DEFN) (OTCQB: DFMTF) (FSE: 35D) announces that it has...

Alveo Technologies and Royal GD To Expand Poultry Testing Portfolio Beyond Avian Influenza

Expanded collaboration adds additional notifiable disease and respiratory targets impacting poultry production to Alveo's molecular testing platform, delivering lab-quality answers in under an hour...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsViruses

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers